Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -4.50% vs -5.86% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 8.26% vs 2,50,600.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 17.26% vs -7.98% in Mar 2025
Compare Balance Sheet Results of Par Drugs & Che.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.30
24.99
-12.69
-50.78%
Share Warrants & Outstandings
Total Reserve
99.68
124.17
-24.49
-19.72%
Shareholder's Funds
111.98
149.16
-37.18
-24.93%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.72
-0.72
-100.00%
Secured Loans
0.00
0.72
-0.72
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.24
1.41
1.83
129.79%
Other Long Term Liabilities
0.00
0.41
-0.41
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.24
0.00
0.24
0.00%
Total Non-Current Liabilities
3.48
2.54
0.94
37.01%
Current Liabilities
Trade Payables
8.19
29.23
-21.04
-71.98%
Other Current Liabilities
0.96
12.90
-11.94
-92.56%
Short Term Borrowings
0.00
17.55
-17.55
-100.00%
Short Term Provisions
4.59
0.00
4.59
0.00%
Total Current Liabilities
13.74
59.68
-45.94
-76.98%
Total Liabilities
129.21
211.38
-82.17
-38.87%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
75.98
34.60
41.38
119.60%
Less: Accumulated Depreciation
39.54
11.58
27.96
241.45%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
36.44
23.01
13.43
58.37%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.72
27.81
-27.09
-97.41%
Intangible assets under development
0.00
1.44
-1.44
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
27.14
8.19
18.95
231.38%
Long Term Loans & Advances
0.00
3.97
-3.97
-100.00%
Other Non Current Assets
0.59
0.00
0.59
0.00%
Total Non-Current Assets
64.89
64.42
0.47
0.73%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.37
32.76
-27.39
-83.61%
Sundry Debtors
12.03
80.72
-68.69
-85.10%
Cash and Bank
41.84
16.44
25.40
154.50%
Other Current Assets
4.75
1.09
3.66
335.78%
Short Term Loans and Advances
0.33
15.95
-15.62
-97.93%
Total Current Assets
64.33
146.96
-82.63
-56.23%
Net Current Assets (Including Current Investments)
50.58
87.28
-36.70
-42.05%
Total Current Assets Excluding Current Investments
64.33
146.96
-82.63
-56.23%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
129.21
211.38
-82.17
-38.87%
Contingent Liabilities
0.10
118.10
-118.00
-99.92%
Total Debt
0.00
18.26
-18.26
-100.00%
Book Value per share (adjusted)
91.01
59.69
31.32
52.47%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 37.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -4.50% vs -5.86% in Mar 2025
Annual - Investments
Investments 27.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.26% vs 2,50,600.00% in Mar 2025
Annual - Current Assets
Current Assets 64.33 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.26% vs -7.98% in Mar 2025






